References
- Petty TL, Weinmann GG. Building a national strategy for the prevention and management of and research in chronic obstructive pulmonary disease. National Heart, Lung, and Blood Institute Workshop Summary: Bethesda, Md, August 29–31, 1995. JAMA 1997; 277(3):246–53
- Petty TL. A new national strategy for COPD. J Respir Dis 1997; 18(4):365–9
References
- Petty TL. The worldwide epidemiology of chronic obstructive pulmonary disease. Curr Opin Pulm Med 1996; 2(2):84–9
- Petty TL, Silvers GW, Stanford RE. Mild emphysema is associated with reduced elastic recoil and increased lung size but not with air-flow limitation. Am Rev Respir Dis 1987; 136(4):867–71
- Burrows B, Knudson RJ, Camilli AE, et al. The “horse-racing effect” and predicting decline in forced expiratory volume in one second from screening spirometry. Am Rev Respir Dis 1987; 135(4):788–93
- Strategies in preserving lung health and preventing COPD and associated diseases: the National Lung Health Education Program (NLHEP). Chest 1998; 113(2 Suppl): 123–63S
- Anthonisen NR, Connett JE, Kiley JP, et al. Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1: the Lung Health Study. JAMA 1994; 272(19):1497–505
- Sachs DP. Effectiveness of the 4-mg dose of nicotine polacrilex for the initial treatment of high-dependent smokers. Arch Intern Med 1995; 155(18):1973–80
- Fiore MC, Smith SS, Jorenby DE, et al. The effectiveness of the nicotine patch for smoking cessation: a meta-analysis. JAMA 1994: 271(24): 1940–7
- Tonnesen P, Mikkelsen K, Norregaard J, et al. Recycling of hard-core smokers with nicotine nasal spray. Eur Respir J 1996; 9(8):1619–23
- Peto R, Speizer FE, Cochrane AL, et al. The relevance in adults of air-flow obstruction, but not of mucus hypersecretion, to mortality from chronic lung disease: results from 20 years of prospective observation. Am Rev Respir Dis 1983; 128(3):491–500
- Morris JF, Temple W. Spirometrie “lung age” estimation for motivating smoking cessation. Prev Med 1985; 14(5):655–62
- Petty TL. It's never too late to stop smoking: but how old are your lungs? (Editorial) JAMA 1993; 269(21):2785
- Petty TL. COPD in the setting of ‘multidimensional’ illness. Hosp Pract 1988; 23(1A):39–50
- Fiebach N, Beckett W. Prevention of respiratory infections in adults: influenza and pneumococcal vaccines. Arch Intern Med 1994; 154(22):2545–57 [Erratum, Arch Intern Med 1995; 155(2):218]
- Braun SR, McKenzie WN, Copeland C, et al. A comparison of the effect of ipratropium and albuterol in the treatment of chronic obstructive airway disease. Arch Intern Med 1989;149(3):544–7 [Erratum, Arch Intern Med 1990;150(6):1242]
- Rennard SI, Serby CW, Ghafouri M, et al. Extended therapy with ipratropium is associated with improved lung function in patients with COPD: a retrospective analysis of data from seven clinical trials. Chest 1996; 110(1):62–70
- COMBI VENT Inhalation Aerosol Study Group. In chronic obstructive pulmonary disease, a combination of ipratropium and albuterol is more effective than either agent alone: an 85-day multicenter trial. Chest 1994; 105 (5): 1411–9
- Dompeling E, van Schayck CP, van Grunsven PM, et al. Slowing the deterioration of asthma and chronic obstructive pulmonary disease observed during bronchodilator therapy by adding inhaled corticosteroids: a 4-year prospective study. Ann Intern Med 1993; 118(10):770–8
- Postma DS, Steenhuis EJ, van der Weele LT, et al. Severe chronic airflow obstruction: can corticosteroids slow down progression? Eur J Respir Dis 1985; 67(1):56–64
- Postma DS, Peters I, Steenhuis EJ, et al. Moderately severe chronic airflow obstruction: can corticosteroids slow down obstruction? Eur Respir J 1988; 1(1): 22–6
- Callahan CM, Dittus RS, Katz BP. Oral corticosteroid therapy for patients with stable chronic obstructive pulmonary disease: a meta-analysis. Ann Intern Med 1991; 114(3): 216–23